[go: up one dir, main page]

AR002945A1 - Acidos 4-biarilbutirico o 5-biarilpentanoico sustituidos y sus derivados como inhibidores de las metaloproteasas de matriz, composicion que los contiene, y metodos para la preparacion de dichos compuestos - Google Patents

Acidos 4-biarilbutirico o 5-biarilpentanoico sustituidos y sus derivados como inhibidores de las metaloproteasas de matriz, composicion que los contiene, y metodos para la preparacion de dichos compuestos

Info

Publication number
AR002945A1
AR002945A1 ARP950100171A AR10017195A AR002945A1 AR 002945 A1 AR002945 A1 AR 002945A1 AR P950100171 A ARP950100171 A AR P950100171A AR 10017195 A AR10017195 A AR 10017195A AR 002945 A1 AR002945 A1 AR 002945A1
Authority
AR
Argentina
Prior art keywords
group
derivatives
substituted
compounds
preparation
Prior art date
Application number
ARP950100171A
Other languages
English (en)
Original Assignee
Bayer Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/539,409 external-priority patent/US5789434A/en
Application filed by Bayer Corp filed Critical Bayer Corp
Publication of AR002945A1 publication Critical patent/AR002945A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Acidos 4-biarilbutírico o 5-biarilpentanoico substituidos y sus derivados que tienen actividad inhibitoria de la metaloproteasa de la matriz,caracterizados por la fórmula (T)x A-B-D-E-G, donde A y B son anillos de arilo o heteroarilo;ca da T es un grupo de sustitución; x es 0, 1 ó 2; el grupo Drepresenta (II); el grupo E representa una cadena de dos o tres carbonos que lleva de uno a dos grupos de sustitución que son independientes o estánasociados en una formación de anillo,mos trándose las posibles estructuras en el texto y en las afirmaciones; y el grupo G representa -PO3H2, -M, y III en elque M represente -CO2H,-CON(R11)2 ó -CO2R12; y R13 representa cualquiera de las cadenas laterales de 19 aminoácidos no cíclicosque aparecen de forma natural,e incluye, por lo tanto, sales farmacéuticamente aceptables. También se relaciona con una composición que tiene actividad inhibitoria de la metaloproteasa de la matriz y un método para la preparación de dichoscompue stos.
ARP950100171A 1994-11-15 1995-11-14 Acidos 4-biarilbutirico o 5-biarilpentanoico sustituidos y sus derivados como inhibidores de las metaloproteasas de matriz, composicion que los contiene, y metodos para la preparacion de dichos compuestos AR002945A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33984694A 1994-11-15 1994-11-15
US08/539,409 US5789434A (en) 1994-11-15 1995-11-06 Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors

Publications (1)

Publication Number Publication Date
AR002945A1 true AR002945A1 (es) 1998-05-27

Family

ID=26991840

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP950100171A AR002945A1 (es) 1994-11-15 1995-11-14 Acidos 4-biarilbutirico o 5-biarilpentanoico sustituidos y sus derivados como inhibidores de las metaloproteasas de matriz, composicion que los contiene, y metodos para la preparacion de dichos compuestos

Country Status (5)

Country Link
US (1) US6166082A (es)
AR (1) AR002945A1 (es)
HR (1) HRP950558A2 (es)
IL (1) IL115995A0 (es)
TR (1) TR199501429A2 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6900194B1 (en) 1998-12-30 2005-05-31 Bayer Aktiengesellschaft Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases
US7396810B1 (en) * 2000-08-14 2008-07-08 Oregon Health Sciences University Compositions and methods for treating cancer by modulating HER-2 and EGF receptors
US7625859B1 (en) * 2000-02-16 2009-12-01 Oregon Health & Science University HER-2 binding antagonists
US7393823B1 (en) 1999-01-20 2008-07-01 Oregon Health And Science University HER-2 binding antagonists
AU2001245862A1 (en) * 2000-03-21 2001-10-03 The Procter & Gamble Company Difluorobutyric acid metalloprotease inhibitors
WO2001070690A1 (en) * 2000-03-21 2001-09-27 The Procter & Gamble Company Heterocyclic side chain containing metalloprotease inhibitors
AU2001249269A1 (en) * 2000-03-21 2001-10-03 The Procter & Gamble Company Carbocyclic side chain containing metalloprotease inhibitors
HUP0300235A2 (hu) * 2000-03-21 2003-08-28 The Procter & Gamble Co. Heterociklikus oldalláncot tartalmazó, N-szubsztituált metalloproteáz inhibitorok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
CA2511521C (en) 2002-12-30 2012-02-07 Angiotech International Ag Drug delivery from rapid gelling polymer composition
WO2005016864A1 (en) * 2003-07-29 2005-02-24 The Arizona Disease Control Research Commission Conjugated nitro alkene anticancer agents based on isoprenoid metabolism
WO2006042002A2 (en) * 2004-10-05 2006-04-20 Oregon Health And Science University Compositions and methods for treating disease

Family Cites Families (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3182061A (en) * 1961-03-20 1965-05-04 Warner Lambert Pharmaceutical 5-[4-(p-hydroxyphenoxy)phenyl]-5-oxo-3-methylvaleric acid
FR5035M (es) * 1964-07-28 1967-05-02
US3624142A (en) * 1964-09-10 1971-11-30 Merck & Co Inc Substituted biphenyl acetic acid derivatives
GB1121722A (en) * 1966-03-31 1968-07-31 Ici Ltd New carboxylic acid derivatives
US3707549A (en) * 1967-12-05 1972-12-26 Lilly Co Eli Alpha-substituted hydrocinnamic acids and derivatives thereof
US3754021A (en) * 1968-05-29 1973-08-21 Merck & Co Inc 4-keto-4-(3-chloro-4'-cyclohexyl)phenylbutyric acid and related compounds
US3876800A (en) * 1969-05-12 1975-04-08 Clin Midy Pharmaceutical compositions and methods for treating inflammation and pain
FR2104632A1 (en) * 1969-09-03 1972-04-21 Aries Robert Salicyloyloxy substd aralkanoic acids - analgesics, anticonvulsants antiinflammatories antipyretics, antirheumatics
US3917846A (en) * 1970-05-05 1975-11-04 William H Roher Inc Phenylacetic acids in reducing pain, fever and inflammation
US3867434A (en) * 1971-11-04 1975-02-18 Rorer Inc William H Phenyl butyric acids and derivatives thereof
US3784701A (en) * 1970-09-21 1974-01-08 American Cyanamid Co Compositions containing substituted benzoylpropionic acids and method of use to treat inflammation and pain
US3997589A (en) * 1971-03-17 1976-12-14 Boehringer Ingelheim Gmbh 4-(2'-Fluoro-4-biphenylylr-4-oxo-butyric acid and esters and salts thereof
US4021479A (en) * 1971-03-17 1977-05-03 Boehringer Ingelheim Gmbh Derivatives of 4-(4-biphenylyl)-butyric acid
US3749750A (en) * 1971-06-25 1973-07-31 American Home Prod Alkyl esters of substituted phenylsulfonyl alkanoic acids
BE787782A (fr) * 1971-08-20 1973-02-19 Thomae Gmbh Dr K Nouveaux 4-(4-biphenylyl)-butyramides
CS187460B2 (en) * 1974-03-01 1979-01-31 Merck Patent Gmbh Process for preparing new derivatives of phenylbutanole
US3962228A (en) * 1974-03-18 1976-06-08 American Home Products Corporation 3-benzoylpropionamido cephalosporanic derivatives
FR2300551A2 (fr) * 1975-02-17 1976-09-10 Fabre Sa Pierre Nouveaux
GB1498903A (en) * 1974-03-25 1978-01-25 Fabre Sa Pierre Aromatic keto-acids and their derivatives
AT336589B (de) * 1974-05-20 1977-05-10 Thomae Gmbh Dr K Verfahren zur herstellung von neuen biphenylderivaten
US4151302A (en) * 1975-06-28 1979-04-24 Merck Patent Gesellschaft Mit Beschrankter Haftung Araliphatic dihalogen compounds composition and method of use
US4168385A (en) * 1975-09-25 1979-09-18 American Cyanamid Company Hypolipemic phenylacetic acid derivatives
FR2378741A1 (fr) * 1977-02-01 1978-08-25 Fabre Sa Pierre Acides garyl goxo isovaleriques doues de proprietes antiphlogistiques et antalgiques
ATE1855T1 (de) * 1978-09-08 1982-12-15 Imperial Chemical Industries Plc Antiarthritische hydroxyessigsaeurederivate, pharmazeutische zusammensetzungen daraus und verfahren zu ihrer herstellung.
DE2854475A1 (de) * 1978-12-16 1980-07-03 Basf Ag Neue 3,4-diaza-bicyclo eckige klammer auf 4.1.0 eckige klammer zu hepten-(2)- one-(5), verfahren zu ihrer herstellung und diese verbindungen enthaltende therapeutische mittel
US4247466A (en) * 1979-07-05 1981-01-27 American Cyanamid Company Lactone metabolites of 3-(4-biphenylylcarbonyl)propionic acid
US4219668A (en) * 1979-07-05 1980-08-26 American Cyanamid Company 4-Hydroxy,4-biphenylbutyric acid
US4271191A (en) * 1979-12-19 1981-06-02 Pierre Fabre S.A. Method of treating hyperuricemia and gout
FR2503140A1 (fr) * 1981-03-31 1982-10-08 Fabre Sa Pierre Acides biphenyl-4 oxo-4 methylene-3 butyriques, leur procede de preparation et leur utilisation comme medicaments
US4577025A (en) * 1981-12-21 1986-03-18 Nissan Chemical Industries, Ltd. Method of preparing α-aromatic propionic acids and intermediates thereof
JPS58150563A (ja) * 1982-03-04 1983-09-07 Taisho Pharmaceut Co Ltd ３−ベンゾイル−２−メルカプトプロピオン酸誘導体
JPS6054356A (ja) * 1983-09-03 1985-03-28 Taisho Pharmaceut Co Ltd ３−ベンゾイル−２−メルカプトプロピオン酸誘導体
JPS60209539A (ja) * 1984-04-04 1985-10-22 Hitachi Ltd ネマチツク液晶化合物並びに液晶組成物
CS243570B1 (en) * 1984-08-31 1986-06-12 Miroslav Kuchar Omega-aryloxoalkane acids
JPS61200963A (ja) * 1985-02-28 1986-09-05 Taisho Pharmaceut Co Ltd ジフエニルスルフイド誘導体
JPS61200964A (ja) * 1985-02-28 1986-09-05 Taisho Pharmaceut Co Ltd ３−ベンゾイル−３−メルカプトプロピオン酸誘導体
DE3525284A1 (de) * 1985-07-16 1987-01-29 Boehringer Mannheim Gmbh Neue carbonsaeurederivate, verfahren zu ihrer herstellung, ihre verwendung sowie arzneimittel, die diese verbindungen enthalten
JPH0228579B2 (ja) * 1985-12-03 1990-06-25 Taisho Pharma Co Ltd Menekikinofuzenchiryozai
JPS6388168A (ja) * 1986-10-01 1988-04-19 Taisho Pharmaceut Co Ltd ３−ベンゾイルプロピオン酸誘導体
IE60751B1 (en) * 1986-12-24 1994-08-10 Beecham Group Plc Derivatives of n-(2-alkyl-3-mercapto-glutaryl) alpha-amino acids and their use as collagenase inhibitors
US5098613A (en) * 1987-01-12 1992-03-24 Eli Lilly And Company Anti-inflammatory agents
DE3700732A1 (de) * 1987-01-13 1988-07-21 Boehringer Mannheim Gmbh Neue carbonsaeurederivate, verfahren zu ihrer herstellung sowie arzneimittel, die diese verbindungen enthalten
GB8814813D0 (en) * 1988-06-22 1988-07-27 Beecham Group Plc Novel compounds
CS276833B6 (en) * 1990-06-18 1992-08-12 Vyzk Ustav Farm Biochem Sp Functional derivatives of 4-(2,4-difluorobiphenylyl)-2-methyl -4- oxobutanoic acid
JPH04128262A (ja) * 1990-09-18 1992-04-28 Taisho Pharmaceut Co Ltd ３―ベンゾイルプロピオン酸誘導体
JP3031701B2 (ja) * 1990-11-27 2000-04-10 チッソ株式会社 ラクトン化合物および組成物
GB9027023D0 (en) * 1990-12-12 1991-01-30 Wellcome Found Anti-atherosclerotic aryl compounds
DE4102024A1 (de) * 1991-01-24 1992-07-30 Thomae Gmbh Dr K Biphenylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US5250552A (en) * 1991-05-09 1993-10-05 Warner-Lambert Company 3-[thiazolidinone, oxazolidinone, imidazolidinone]-indoles as antiinflammatory agents
FR2679564A1 (fr) * 1991-07-23 1993-01-29 Inst Nat Sante Rech Med Nouveaux acylmercaptoalcanoldipeptides, leur preparation et les compositions qui les contiennent.
US5273990A (en) * 1992-09-03 1993-12-28 Ciba-Geigy Corporation Phosphono substituted tetrazole derivatives
JPH05125029A (ja) * 1991-11-06 1993-05-21 Yamanouchi Pharmaceut Co Ltd 新規なアミド化合物又はその塩
PH30449A (en) * 1991-11-25 1997-05-28 Lilly Co Eli Substituted phenyl phenol leukotriene antagonists
SK280617B6 (sk) * 1992-01-16 2000-05-16 Hoechst Aktiengesellschaft Arylcykloalkylové deriváty, spôsob ich prípravy, f
US5217996A (en) * 1992-01-22 1993-06-08 Ciba-Geigy Corporation Biaryl substituted 4-amino-butyric acid amides
US5525629A (en) * 1992-04-07 1996-06-11 British Bio-Technology Limited Inhibition of cytokine production
AU5292193A (en) * 1992-10-02 1994-04-26 Merck & Co., Inc. N-(mercaptoacyl)peptidyl derivatives as antidegenerative agents
JPH06234754A (ja) * 1993-02-10 1994-08-23 Dai Ichi Seiyaku Co Ltd 複素環式カルボン酸誘導体
US5565485A (en) * 1993-03-19 1996-10-15 Merck & Co., Inc. Biphenyl compounds useful or endothelin antagonists
US5536751A (en) * 1994-05-09 1996-07-16 The United States Of America As Represented By The Secretary Of The Army Pharmaceutical alpha-keto carboxylic acid compositions method of making and use thereof
US5789434A (en) * 1994-11-15 1998-08-04 Bayer Corporation Derivatives of substituted 4-biarylbutyric acid as matrix metalloprotease inhibitors
US5648524A (en) * 1995-12-26 1997-07-15 Industrial Technology Research Institute Method for the preparation of 3-benzylthio-2-alkylpropionic acid and its derivatives
US5760276A (en) * 1997-03-06 1998-06-02 Allergan Aryl-and heteroarylcyclohexenyl substituted alkenes having retinoid agonist, antagonist or inverse agonist type biological activity
US6399612B1 (en) * 1997-10-06 2002-06-04 Warner-Lambert Company Heteroaryl butyric acids and their derivatives as inhibitors of matrix metalloproteinases

Also Published As

Publication number Publication date
HRP950558A2 (en) 1997-12-31
IL115995A0 (en) 1996-01-31
US6166082A (en) 2000-12-26
TR199501429A2 (tr) 1996-06-21

Similar Documents

Publication Publication Date Title
YU71295A (sh) Supstituisane 4-biarilbuterne ili 5-biaril pentanoinske kiseline i njihovi derivati kao matrični metaloproteazni inhibitori
ES2136037A1 (es) Inhibidores de sulfamida-metaloproteasa
ES2116131T3 (es) Derivados de naftaleno, su procedimiento de preparacion y productos intermediarios adecuados, y las composiciones farmaceuticas que los contienen.
AR002945A1 (es) Acidos 4-biarilbutirico o 5-biarilpentanoico sustituidos y sus derivados como inhibidores de las metaloproteasas de matriz, composicion que los contiene, y metodos para la preparacion de dichos compuestos
AR042572A1 (es) Derivados de acido lipoico, procedimiento para su preparacion, medicamentos y composiciones farmaceuticas que los contienen y utilizacion de dichos derivados para la preparacion de los referidos medicamentos
EA200400944A1 (ru) Замещенные производные тетрациклина, фармацевтическая композиция и способ лечения субъекта с их использованием
AR002751A1 (es) Antifungicos de tetrahidrofurano, composiciones farmaceuticas que los contienen y el uso de los compuestos para preparar composiciones farmaceuticas utiles para el tratamiento de infecciones fungicas
AR009357A1 (es) Compuesto de amidas de acido fosfinico y sus usos para preparar una composicion farmaceutica y en un metodo para prevenir o tratar unaenfermedad asociada a la actividad de metaloproteasa
PT88251A (pt) Processo para a preparacao de novos derivados de ariloxi-indenamina com actividade antidepressiva e de composicoes farmaceuticas que os contem
PT99267A (pt) Processo para a preparacao de novos derivados de mercaptoacetilamida e de composicoes farmaceuticas que os contem
CZ284872B6 (cs) Cyklické močoviny a jejich analogy a farmaceutické přípravky na jejich bázi
ID18143A (id) Penghambat metaloprotease amina siklik tersubstitusi
DK0920410T3 (da) Fremgangsmåde til fremstilling af cyclohexencarboxylatderivater
CY1108529T1 (el) Νεα αζαδικυκλικα παραγωγα, μεθοδος παρασκευης τους και φαρμακευτικες συνθεσεις που τα περιεχουν
MX9207449A (es) Inhibidores de la enzima proteolitica derivada de sacarina.
UY27853A1 (es) Difenilazetidinonas sustituidas en grupo acido, procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso.
ES2033985T3 (es) Un procedimiento para la preparacion de una composicion farmaceutica.
ES2175155T3 (es) Cetoacidos aromaticos y sus derivados como inhibidores de las metaloproteinasas matriciales.
NI200900147A (es) Nuevos derivados tricíclicos su procedimiento de preparación y las composiciones farmacéuticas que los contienen.
MY117687A (en) Substituted 4-biphenyl-4-hydroxybutric acid derivatives as matrix metalloprotease inhibitors
DE69614824D1 (de) Verfahren zur herstellung von retrovial protease hemmenden zwischenprodukten
MX9300628A (es) Nuevos derivados de taxano, procedimiento para su preparacion y composicion farmaceutica que los contiene.
ES2046193T3 (es) Un procedimiento para la preparacion de un compuesto de imidazolidinona.
DK0656001T3 (da) Nye 2-substituerede indan-2-mercaptoacetylamid-tricycliske derivater til anvendelse som enkefalinasehæmmere
ES2029879T3 (es) Procedimiento para producir derivados de aminas sustituidas.

Legal Events

Date Code Title Description
FG Grant, registration